5-[3-[2-fluoro-4-[3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]prop-1-ynyl]phenoxy]propyl]-2-[[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]-pent-4-ynylamino]-1,3-thiazole-4-carboxylic acid
C45H54FN7O6S2Si — CID 155592281
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[3-[2-fluoro-4-[3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]prop-1-ynyl]phenoxy]propyl]-2-[[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]-pent-4-ynylamino]-1,3-thiazole-4-carboxylic acid
5-[3-[2-fluoro-4-[3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]prop-1-ynyl]phenoxy]propyl]-2-[[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]-pent-4-ynylamino]-1,3-thiazole-4-carboxylic acid (PubChem CID 155592281) has the molecular formula C45H54FN7O6S2Si and a molecular weight of 900.19 g/mol. Its IUPAC name is 5-[3-[2-fluoro-4-[3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]prop-1-ynyl]phenoxy]propyl]-2-[[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]-pent-4-ynylamino]-1,3-thiazole-4-carboxylic acid.
Molecular Properties
| Compound Name | 5-[3-[2-fluoro-4-[3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]prop-1-ynyl]phenoxy]propyl]-2-[[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]-pent-4-ynylamino]-1,3-thiazole-4-carboxylic acid |
|---|---|
| PubChem CID | 155592281 |
| Molecular Formula | C45H54FN7O6S2Si |
| Molecular Weight | 900.19 g/mol |
| Exact Mass | 899.33 |
| IUPAC Name | 5-[3-[2-fluoro-4-[3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]prop-1-ynyl]phenoxy]propyl]-2-[[5-methyl-6-[[3-(2-trimethylsilylethoxymethyl)-1,3-benzothiazol-2-ylidene]amino]pyridazin-3-yl]-pent-4-ynylamino]-1,3-thiazole-4-carboxylic acid |
| SMILES | C#CCCCN(c1cc(C)c(/N=c2\sc3ccccc3n2COCC[Si](C)(C)C)nn1)c1nc(C(=O)O)c(CCCOc2ccc(C#CCN(C)C(=O)OC(C)(C)C)cc2F)s1 |
| InChI | InChI=1S/C45H54FN7O6S2Si/c1-10-11-14-24-52(38-28-31(2)40(50-49-38)48-43-53(30-57-26-27-62(7,8)9)34-18-12-13-19-36(34)60-43)42-47-39(41(54)55)37(61-42)20-16-25-58-35-22-21-32(29-33(35)46)17-15-23-51(6)44(56)59-45(3,4)5/h1,12-13,18-19,21-22,28-29H,11,14,16,20,23-27,30H2,2-9H3,(H,54,55)/b48-43- |
| InChIKey | YPIORNNBOXNQJV-HKTXRNFJSA-N |
| XLogP | 9.42 |
| TPSA | 144.50 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 62 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 900.19 |
| LogP ≤ 5 | 9.42 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155592281 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.